Download PDF
Am J Perinatol 2021; 38(05): 482-489
DOI: 10.1055/s-0039-1698832
Original Article

Subfoveal Choroidal Thickness and Associated Changes of Angiogenic Factors in Women with Severe Preeclampsia

Conrad N. Stern-Ascher
1   Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University, New York
2   Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York
3   Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina
,
Victoria S. North
4   Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
,
Aakriti Garg
2   Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York
,
Cande V. Ananth
5   Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Epidemiology and Biostatistics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
6   Department of Health Policy and Management, Joseph L. Mailman School of Public Health, Columbia University, New York
7   Environmental and Occupational Health Sciences Institute, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey
,
Ronald J. Wapner
1   Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University, New York
,
Srilaxmi Bearelly
2   Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York
› Author Affiliations Funding Financial support was received from The New York Community Trust—Frederick J and Theresa Dow Wallace Fund, Columbia University (S.B.).
› Further Information
    Permissions and Reprints

Abstract

Objective Severe preeclampsia complicates roughly 1% of all pregnancies. One defining feature of severe preeclampsia is new onset visual disturbance. The accessibility of the choroid to high-resolution, noninvasive imaging makes it a reasonable target of investigation for disease prediction, stratification, or monitoring in preeclampsia. This study aimed to compare subfoveal choroidal thickness between women with severe preeclampsia and those with normotensive pregnancies, and to investigate associations between such findings and other indicators of disease severity, including gestational age and serum angiogenic factors.

Study Design We designed a case-control study comprised of 36 women diagnosed with severe preeclampsia (cases) matched to 37 normotensive women (controls) by race/ethnicity and parity, all diagnosed in the postpartum period. All patients underwent enhanced depth imaging spectral-domain optical coherence tomography and serum analysis.

Results Cases showed no difference in subfoveal choroidal thickness compared with controls (p = 0.65). Amongst cases, subfoveal choroidal thickness and gestational age at delivery were inversely related (r = 0.86, p < .001). There was a positive association of placental growth factor with subfoveal choroidal thickness amongst cases (r = 0.54, p = 0.002).

Conclusion This study suggests a relationship between the degree of disease severity and the magnitude of choroidal thickening. We also show an association between this index and placental growth factor level in the postpartum period.

Keywords

EDI SD-OCT - placental growth factor - preeclampsia with severe features - soluble endoglin - soluble fms-like tyrosine kinase - subfoveal choroidal thickness

Condensation

Subfoveal choroidal thickness is increased in patients with preeclampsia diagnosed at earlier GAs as compared with later GAs and those patients without hypertensive disorders of pregnancy.




Publication History

Received: 19 April 2019

Accepted: 07 September 2019

Article published online:
04 November 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
    CrossrefPubMedGoogle Scholar
  • 2 Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 2013; 347: f6564
    CrossrefPubMedGoogle Scholar
  • 3 Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22 (02) 203-212
    CrossrefPubMedGoogle Scholar
  • 4 Sheth BP, Mieler WF. Ocular complications of pregnancy. Curr Opin Ophthalmol 2001; 12 (06) 455-463
    CrossrefPubMedGoogle Scholar
  • 5 Roos NM, Wiegman MJ, Jansonius NM, Zeeman GG. Visual disturbances in (pre)eclampsia. Obstet Gynecol Surv 2012; 67 (04) 242-250
    CrossrefPubMedGoogle Scholar
  • 6 Somfai GM, Miháltz K, Tulassay E, Rigó Jr J. Diagnosis of serous neuroretinal detachments of the macula in severe preeclamptic patients with optical coherence tomography. Hypertens Pregnancy 2006; 25 (01) 11-20
    CrossrefPubMedGoogle Scholar
  • 7 Pastore MR, De Benedetto U, Gagliardi M, Pierro L. Characteristic SD-OCT findings in preeclampsia. Ophthalmic Surg Lasers Imaging 2012; 43 (6, Suppl): S139-S141
    CrossrefPubMedGoogle Scholar
  • 8 Lin P, Hahn P, Fekrat S. Peripheral retinal vascular leakage demonstrated by ultra-widefield fluorescein angiography in preeclampsia with HELLP syndrome. Retina 2012; 32 (08) 1689-1690
    CrossrefPubMedGoogle Scholar
  • 9 Neudorfer M, Spierer O, Goder M. et al. The prevalence of retinal and optical coherence tomography findings in preeclamptic women. Retina 2014; 34 (07) 1376-1383
    CrossrefPubMedGoogle Scholar
  • 10 Fastenberg DM, Fetkenhour CL, Choromokos E, Shoch DE. Choroidal vascular changes in toxemia of pregnancy. Am J Ophthalmol 1980; 89 (03) 362-368
    CrossrefPubMedGoogle Scholar
  • 11 Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10 (08) 466-480
    CrossrefPubMedGoogle Scholar
  • 12 Matias DS, Costa RF, Matias BS, Gordiano L, Correia LC. Predictive value of ophthalmic artery Doppler velocimetry in relation to development of pre-eclampsia. Ultrasound Obstet Gynecol 2014; 44 (04) 419-426
    CrossrefPubMedGoogle Scholar
  • 13 Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C. et al; EBM CONNECT Collaboration. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012; 119 (07) 778-787
    CrossrefPubMedGoogle Scholar
  • 14 Romero R, Nien JK, Espinoza J. et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21 (01) 9-23
    CrossrefPubMedGoogle Scholar
  • 15 Grisanti S, Canbek S, Kaiserling E. et al. Expression of endoglin in choroidal neovascularization. Exp Eye Res 2004; 78 (02) 207-213
    CrossrefPubMedGoogle Scholar
  • 16 Rakic JM, Lambert V, Devy L. et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44 (07) 3186-3193
    CrossrefPubMedGoogle Scholar
  • 17 Garg A, Wapner RJ, Ananth CV. et al. Choroidal and retinal thickening in severe preeclampsia. Invest Ophthalmol Vis Sci 2014; 55 (09) 5723-5729
    CrossrefPubMedGoogle Scholar
  • 18 Kim JW, Park MH, Kim YJ, Kim YT. Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia. Eye (Lond) 2016; 30 (03) 349-354
    CrossrefPubMedGoogle Scholar
  • 19 Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol 2009; 147 (05) 801-810
    CrossrefPubMedGoogle Scholar
  • 20 Flores-Moreno I, Lugo F, Duker JS, Ruiz-Moreno JM. The relationship between axial length and choroidal thickness in eyes with high myopia. Am J Ophthalmol 2013; 155 (02) 314-319
    CrossrefPubMedGoogle Scholar
  • 21 Liu R, Kuang GP, Luo DX, Lu XH. Choroidal thickness in pregnant women: a cross-sectional study. Int J Ophthalmol 2016; 9 (08) 1200-1206
    PubMedGoogle Scholar
  • 22 Sayin N, Kara N, Pirhan D. et al. Subfoveal choroidal thickness in preeclampsia: comparison with normal pregnant and nonpregnant women. Semin Ophthalmol 2014; 29 (01) 11-17
    CrossrefPubMedGoogle Scholar
  • 23 Ataş M, Açmaz G, Aksoy H. et al. Evaluation of the macula, retinal nerve fiber layer and choroid in preeclampsia, healthy pregnant and healthy non-pregnant women using spectral-domain optical coherence tomography. Hypertens Pregnancy 2014; 33 (03) 299-310
    CrossrefPubMedGoogle Scholar
  • 24 Goktas S, Basaran A, Sakarya Y. et al. Measurement of choroid thickness in pregnant women using enhanced depth imaging optical coherence tomography. Arq Bras Oftalmol 2014; 77 (03) 148-151
    CrossrefPubMedGoogle Scholar
  • 25 Ulusoy DM, Duru N, Ataş M, Altınkaynak H, Duru Z, Açmaz G. Measurement of choroidal thickness and macular thickness during and after pregnancy. Int J Ophthalmol 2015; 8 (02) 321-325
    PubMedGoogle Scholar
  • 26 Dadaci Z, Alptekin H, Oncel acir N, Borazan M. Changes in choroidal thickness during pregnancy detected by enhanced depth imaging optical coherence tomography. Br J Ophthalmol 2015; 99 (09) 1255-1259
    CrossrefPubMedGoogle Scholar
  • 27 Levine RJ, Maynard SE, Qian C. et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350 (07) 672-683
    CrossrefPubMedGoogle Scholar
  • 28 Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122 (05) 478-487
    CrossrefPubMedGoogle Scholar
  • 29 Turpin CA, Sakyi SA, Owiredu WK, Ephraim RK, Anto EO. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnancy Childbirth 2015; 15: 189
    CrossrefPubMedGoogle Scholar
  • 30 Petrozella L, Mahendroo M, Timmons B, Roberts S, McIntire D, Alexander JM. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol 2012; 207 (02) 140.e20-140.e26
    CrossrefPubMedGoogle Scholar
  • 31 Wikström AK, Larsson A, Eriksson UJ, Nash P, Olovsson M. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87 (02) 146-153
    CrossrefPubMedGoogle Scholar
  • 32 Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123 (24) 2856-2869
    CrossrefPubMedGoogle Scholar
  • 33 Hannan NJ, Brownfoot FC, Cannon P. et al. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment. Sci Rep 2017; 7 (01) 1819
    CrossrefPubMedGoogle Scholar
  • 34 Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci Rep 2016; 6: 21090
    CrossrefPubMedGoogle Scholar